SI9420017B - Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a - Google Patents

Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a Download PDF

Info

Publication number
SI9420017B
SI9420017B SI9420017A SI9420017A SI9420017B SI 9420017 B SI9420017 B SI 9420017B SI 9420017 A SI9420017 A SI 9420017A SI 9420017 A SI9420017 A SI 9420017A SI 9420017 B SI9420017 B SI 9420017B
Authority
SI
Slovenia
Prior art keywords
hydroxy
substituted
alkyl
unsubstituted
aryl
Prior art date
Application number
SI9420017A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9420017A (en
Inventor
Joseph P. Vacca
James P. Guare
Bruce D. Dorsey
M. Katharine Holloway
Randall W. Hungate
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of SI9420017A publication Critical patent/SI9420017A/sl
Publication of SI9420017B publication Critical patent/SI9420017B/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9420017A 1993-03-31 1994-03-24 Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a SI9420017B (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4072993A 1993-03-31 1993-03-31
PCT/US1994/003209 WO1994022480A1 (en) 1993-03-31 1994-03-24 Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids

Publications (2)

Publication Number Publication Date
SI9420017A SI9420017A (en) 1996-10-31
SI9420017B true SI9420017B (sl) 2003-12-31

Family

ID=21912617

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9420017A SI9420017B (sl) 1993-03-31 1994-03-24 Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a

Country Status (34)

Country Link
EP (1) EP0617968B1 (cs)
JP (1) JPH08508496A (cs)
KR (1) KR100311551B1 (cs)
CN (1) CN1090186C (cs)
AT (1) ATE230610T1 (cs)
AU (1) AU685772B2 (cs)
BG (1) BG62083B1 (cs)
BR (1) BR9406503A (cs)
CA (1) CA2120192A1 (cs)
CY (1) CY2326B1 (cs)
CZ (1) CZ286412B6 (cs)
DE (1) DE69431972T2 (cs)
DK (1) DK0617968T3 (cs)
DZ (1) DZ1766A1 (cs)
ES (1) ES2188604T3 (cs)
FI (1) FI954580A7 (cs)
HR (1) HRP940209B1 (cs)
HU (1) HUT74006A (cs)
IL (1) IL109166A (cs)
LV (1) LV13141B (cs)
NO (1) NO953876L (cs)
NZ (1) NZ265164A (cs)
PL (1) PL310895A1 (cs)
PT (1) PT617968E (cs)
RO (1) RO118000B1 (cs)
RU (1) RU2139052C1 (cs)
SA (1) SA94140745B1 (cs)
SG (1) SG64366A1 (cs)
SI (1) SI9420017B (cs)
SK (1) SK279471B6 (cs)
TW (1) TW307684B (cs)
WO (1) WO1994022480A1 (cs)
YU (1) YU49275B (cs)
ZA (1) ZA942255B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1046727C (zh) * 1993-12-15 1999-11-24 麦克公司 Hiv蛋白酶抑制剂
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5476874A (en) * 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors
AU702122B2 (en) * 1994-10-25 1999-02-11 Merck & Co., Inc. Microbial synthesis of HIV protease inhibitors
US6689761B1 (en) 1995-02-01 2004-02-10 Merck & Co., Inc. Combination therapy for HIV infection
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6538006B1 (en) 1998-07-08 2003-03-25 Pharmacia Corporation Retroviral protease inhibitors
AU6508899A (en) 1998-10-13 2000-05-01 Du Pont Pharmaceuticals Company Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
EA200700243A1 (ru) 2004-07-14 2007-08-31 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы лечения гепатита с
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
NZ553329A (en) 2004-07-22 2010-09-30 Ptc Therapeutics Inc Thienopyridines for treating hepatitis C
RU2281297C2 (ru) * 2004-08-23 2006-08-10 Государственное учреждение Научно-исследовательский институт вирусологии им. Д.И. Ивановского Российской академии медицинских наук Полианионные производные норборнана, способ получения и ингибиторы репродукции вируса иммунодефицита человека на их основе
RU2520967C1 (ru) * 2013-02-08 2014-06-27 Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) СИММЕТРИЧНЫЕ ДИИМИНЫ НА ОСНОВЕ КАМФОРЫ - ИНГИБИТОРЫ РЕПРОДУКЦИИ ВИРУСА ГРИППА (ШТАММ A/California/07/09 (H1N1)pdm09)
CN109528747A (zh) * 2018-12-13 2019-03-29 中国人民解放军总医院 扎西他滨在制备抗菌消炎药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
IL89900A0 (en) * 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
CA2032259A1 (en) * 1989-12-18 1991-06-19 Wayne J. Thompson Hiv protease inhibitors useful for the treatment of aids
KR0184604B1 (ko) * 1990-09-11 1999-05-01 야마야 와따루 신규한 폴리펩타이드 및 그것으로 제조한 항-hiv약제
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors
JPH06508146A (ja) * 1991-06-04 1994-09-14 スミスクライン・ビーチャム・コーポレイション 炭素環および複素環式ｈｉｖプロテアーゼ抑制剤

Also Published As

Publication number Publication date
WO1994022480A1 (en) 1994-10-13
IL109166A (en) 1999-08-17
YU49275B (sh) 2005-03-15
HRP940209A2 (en) 1998-02-28
HU9502860D0 (en) 1995-11-28
CA2120192A1 (en) 1994-10-01
NO953876L (no) 1995-11-30
SK122595A3 (en) 1997-03-05
DK0617968T3 (da) 2003-02-24
EP0617968B1 (en) 2003-01-08
FI954580A0 (fi) 1995-09-27
AU685772B2 (en) 1998-01-29
PL310895A1 (en) 1996-01-08
ATE230610T1 (de) 2003-01-15
DZ1766A1 (fr) 2002-02-17
IL109166A0 (en) 1994-06-24
EP0617968A1 (en) 1994-10-05
NZ265164A (en) 1997-09-22
BR9406503A (pt) 1996-01-02
SG64366A1 (en) 1999-04-27
FI954580L (fi) 1995-09-27
KR100311551B1 (ko) 2001-12-28
HK1009248A1 (en) 1999-05-28
SK279471B6 (sk) 1998-11-04
CZ286412B6 (en) 2000-04-12
AU5921394A (en) 1994-10-06
RU2139052C1 (ru) 1999-10-10
PT617968E (pt) 2003-03-31
HUT74006A (en) 1996-10-28
DE69431972T2 (de) 2003-08-28
HRP940209B1 (en) 2004-04-30
TW307684B (cs) 1997-06-11
CN1120316A (zh) 1996-04-10
DE69431972D1 (de) 2003-02-13
YU15994A (sh) 1999-06-15
RO118000B1 (ro) 2002-12-30
ES2188604T3 (es) 2003-07-01
SA94140745B1 (ar) 2006-07-11
CY2326B1 (en) 2003-11-14
BG100016A (bg) 1996-04-30
SI9420017A (en) 1996-10-31
NO953876D0 (no) 1995-09-29
ZA942255B (en) 1994-11-01
JPH08508496A (ja) 1996-09-10
CZ252895A3 (en) 1996-07-17
BG62083B1 (bg) 1999-02-26
LV13141B (en) 2004-08-20
FI954580A7 (fi) 1995-09-27
KR960701661A (ko) 1996-03-28
CN1090186C (zh) 2002-09-04

Similar Documents

Publication Publication Date Title
SI9420017B (sl) Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a
ES2684120T3 (es) Combinación de un inhibidor de IAP y un taxano
US8207183B2 (en) Inhibitors of IAP
US6890933B1 (en) Kinesin inhibitors
PT100304A (pt) Compostos inibidores de proteases retrovirais, sua preparacao e uso e composicoes farmaceuticas que os contem
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
TR200102568T2 (tr) Amid türevleri.
RU2003102389A (ru) Замещенные производные хиназолина и их применение в качестве ингибиторов
CA2481369A1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
AR018175A1 (es) Compuestos de indol-3-glioxilamidas sustituidas, utiles como medicamentos antitumorales, composiciones farmaceuticas formuladas con dichos derivados,utilizacion de dichos derivados para la preparacion de medicamentos antitumorales y los medicamentos asi preparados.
WO1993013066A1 (en) Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors
RU2004122926A (ru) Замещенные производные хиназолина как ингибиторы ауроракиназы
GB1525958A (en) 2-(heterocyclic substituted alkylsulphinyl)-benzimidazoles and their pharmaceutical compositions
DE69710319D1 (de) Para-substituierte phenylpropansäure derivate als integrin-antagonisten
BR112012020142A2 (pt) moduladores do receptor de nmda com estrutura secundária estabilizada e usos dos mesmos.
HUP0401735A2 (hu) CCR1 receptor antagonista hatású piperazinszármazékok és ezeket tartalmazó gyógyászati készítmények
WO2008141385A1 (en) Viral polymerase inhibitors
RU2002120462A (ru) Замещенные производные N-бензилиндол-3-ил-глиоксиловой кислоты, обладающие противоопухолевым действием (варианты), их кислотно-аддитивные соли и их применение (варианты), фармацевтический препарат, лекарственная форма
TR200000752T2 (tr) Etkin terkibin kontrollü salınımı için ilaç formülü.
FR2586679B1 (fr) Composes heterocycliques, procedes pour leur preparation, et compositions pharmaceutiques les contenant pour inhiber l'enzyme de conversion de l'angiotensine
RU2001126725A (ru) Гетероциклические соединения, их промежуточные продукты и ингибиторы эластазы
ATE18221T1 (de) (1-arylcyclobutyl)(heterocyclyl)methylaminderivate, ihre herstellung und ihre verwendung als arzneimittel.
BR9909326A (pt) Derivados de piridina inibidores de pde iv
TR200200485T2 (tr) Yeni A-500359 türevleri.
GB1126352A (en) Isoquinolinobenzodiazepine derivatives

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20081201